Entrectinib in Two Pediatric Patients With Inflammatory Myofibroblastic Tumors Harboring ROS1 or ALK Gene Fusions

被引：15
作者：
Ambati, Srikanth R. [1 ]
Slotkin, Emily K. [1 ]
Chow-Maneval, Edna [2 ]
Basu, Ellen M. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA
[2] Ignyta, San Diego, CA USA
来源：
JCO PRECISION ONCOLOGY | 2018年 / 2卷
基金：
美国国家卫生研究院;
关键词：
LYMPHOMA KINASE ALK; CLINICAL-RESPONSE; PAN-TRK; INHIBITOR; SARCOMA;
D O I：
10.1200/PO.18.00095
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1 / 6
页数：6
相关论文
共 32 条
  • [1] Ahn M., 2017, J THORAC ONCOL, V12
  • [2] [Anonymous], 2017, NPJ PRECIS ONCOL, DOI DOI 10.1038/s41698-017-0009-y
  • [3] [Anonymous], FDA UNV STREAML PATH
  • [4] Molecular Characterization of Inflammatory Myofibroblastic Tumors With Frequent ALK and ROS1 Gene Fusions and Rare Novel RET Rearrangement
    Antonescu, Cristina R.
    Suurmeijer, Albert J. H.
    Zhang, Lei
    Sung, Yun-Shao
    Jungbluth, Achim A.
    Travis, William D.
    Al-Ahmadie, Hikmat
    Fletcher, Christopher D. M.
    Alaggio, Rita
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2015, 39 (07) : 957 - 967
  • [5] Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications
    Ardini, Elena
    Menichincheri, Maria
    Banfi, Patrizia
    Bosotti, Roberta
    De Ponti, Cristina
    Pulci, Romana
    Ballinari, Dario
    Ciomei, Marina
    Texido, Gemma
    Degrassi, Anna
    Avanzi, Nilla
    Amboldi, Nadia
    Saccardo, Maria Beatrice
    Casero, Daniele
    Orsini, Paolo
    Bandiera, Tiziano
    Mologni, Luca
    Anderson, David
    Wei, Ge
    Harris, Jason
    Vernier, Jean-Michel
    Li, Gang
    Felder, Eduard
    Donati, Daniele
    Isacchi, Antonella
    Pesenti, Enrico
    Magnaghi, Paola
    Galvani, Arturo
    [J]. MOLECULAR CANCER THERAPEUTICS, 2016, 15 (04) : 628 - 639
  • [6] Baur N, 2017, FASEB J, V31
  • [7] Crizotinib in ALK-Rearranged Inflammatory Myofibroblastic Tumor
    Butrynski, James E.
    D'Adamo, David R.
    Hornick, Jason L.
    Dal Cin, Paola
    Antonescu, Cristina R.
    Jhanwar, Suresh C.
    Ladanyi, Marc
    Capelletti, Marzia
    Rodig, Scott J.
    Ramaiya, Nikhil
    Kwak, Eunice L.
    Clark, Jeffrey W.
    Wilner, Keith D.
    Christensen, James G.
    Jaenne, Pasi A.
    Maki, Robert G.
    Demetri, George D.
    Shapiro, Geoffrey I.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (18) : 1727 - 1733
  • [8] Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT) A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology
    Cheng, Donavan T.
    Mitchell, Talia N.
    Zehir, Ahmet
    Shah, Ronak H.
    Benayed, Ryma
    Syed, Aijazuddin
    Chandramohan, Raghu
    Liu, Zhen Yu
    Won, Helen H.
    Scott, Sasinya N.
    Brannon, A. Rose
    O'Reilly, Catherine
    Sadowska, Justyna
    Casanova, Jacklyn
    Yannes, Angela
    Hechtman, Jaclyn F.
    Yao, Jinjuan
    Song, Wei
    Ross, Dara S.
    Oultache, Alifya
    Dogan, Snjezana
    Borsu, Laetitia
    Hameed, Meera
    Nafa, Khedoudja
    Arcila, Maria E.
    Ladanyi, Marc
    Berger, Michael F.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (03) : 251 - 264
  • [9] A clinical and genomic profile of inflammatory myofibroblastic tumors.
    Daniel, Sugganth
    Gay, Laurie M.
    Vergilio, Jo-Anne
    Ross, Jeffrey S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [10] What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC)
    Drilon, A.
    Li, G.
    Dogan, S.
    Gounder, M.
    Shen, R.
    Arcila, M.
    Wang, L.
    Hyman, D. M.
    Hechtman, J.
    Wei, G.
    Cam, N. R.
    Christiansen, J.
    Luo, D.
    Maneval, E. C.
    Bauer, T.
    Patel, M.
    Liu, S. V.
    Ou, S. H. I.
    Farago, A.
    Shaw, A.
    Shoemaker, R. F.
    Lim, J.
    Hornby, Z.
    Multani, P.
    Ladanyi, M.
    Berger, M.
    Katabi, N.
    Ghossein, R.
    Ho, A. L.
    [J]. ANNALS OF ONCOLOGY, 2016, 27 (05) : 920 - 926
1234